Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Tuberculosis

Free Subscription Articles published in J Clin Microbiol Retrieve available abstracts of 37 articles: HTML format

Single Articles

June 2025
1. TU C, Su B, Xiong Y, Xia Z, et al
   Identification and quantification of gyrA variants in fluoroquinolone-resistant Mycobacterium tuberculosis in a MeltArray reaction.
   J Clin Microbiol. 2025 Jun 3:e0014625. doi: 10.1128/jcm.00146.
   PubMed     Abstract available
   
   
   May 2025
2. SERGE DIAGBOUGA P, Djibougou AD, Pease C, Alcaide A, et al
   Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis.
   J Clin Microbiol. 2025 May 14:e0164124. doi: 10.1128/jcm.01641.
   PubMed     Abstract available
   
   
   April 2025
3. TURBAWATY DK, Maulida SN, Anadhea DR, Ritonga MA, et al
   Standard E TB-Feron ELISA and Standard F TB-Feron FIA positivity rates and agreement with QuantiFERON-TB Gold Plus among TB high-risk population in Bandung, Indonesia.
   J Clin Microbiol. 2025;63:e0148624.
   PubMed     Abstract available
   
   
   March 2025
4. EIGNER U, Koffer J, Betz U, Koglin J, et al
   Evaluation of the cobas MTB and MTB-RIF/INH assay in clinical samples for the detection of Mycobacterium tuberculosis in respiratory specimens.
   J Clin Microbiol. 2025 Mar 25:e0195924. doi: 10.1128/jcm.01959.
   PubMed     Abstract available
   
   
   
5. YU S, Liu N, Xie Z, Zeng Y, et al
   Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China.
   J Clin Microbiol. 2025 Mar 19:e0181324. doi: 10.1128/jcm.01813.
   PubMed     Abstract available
   
   
   
6. CUELLA-MARTIN I, Runyambo D, De Bock S, Diels M, et al
   Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.
   J Clin Microbiol. 2025 Mar 3:e0180624. doi: 10.1128/jcm.01806.
   PubMed     Abstract available
   
   
   February 2025
7. SCHWAB TC, Joseph L, Moono A, Goller PC, et al
   Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and Zambia.
   J Clin Microbiol. 2025 Feb 12:e0139024. doi: 10.1128/jcm.01390.
   PubMed     Abstract available
   
   
   January 2025
8. RICKMAN HM, Phiri MD, Mbale H, Horton KC, et al
   Low concordance between QIAreach QuantiFERON-TB, a novel interferon-gamma release assay, and QuantiFERON-TB Gold Plus, in a population-based survey in Blantyre, Malawi.
   J Clin Microbiol. 2025;63:e0132324.
   PubMed     Abstract available
   
   
   December 2024
9. OLSON AM, Wood RC, Weigel KM, Yan AJ, et al
   High-sensitivity detection of Mycobacterium tuberculosis DNA in tongue swab samples.
   J Clin Microbiol. 2024 Dec 31:e0114024. doi: 10.1128/jcm.01140.
   PubMed     Abstract available
   
   
   November 2024
10. CHAN H-H, Wang Y-C, Jou R
    A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing.
    J Clin Microbiol. 2024 Nov 18:e0122724. doi: 10.1128/jcm.01227.
    PubMed     Abstract available
    
    
    October 2024
11. GAEDDERT M, Glaser K, Chendi BH, Sultanli A, et al
    Host blood protein biomarkers to screen for tuberculosis disease: a systematic review and meta-analysis.
    J Clin Microbiol. 2024 Oct 24:e0078624. doi: 10.1128/jcm.00786.
    PubMed     Abstract available
    
    
    September 2024
12. LUUKINEN B, Aittoniemi J, Miikkulainen-Lahti T, Mentula S, et al
    Evaluation of the STANDARD M10 MDR-TB and MTB/NTM assays for the detection of Mycobacterium tuberculosis, rifampicin and isoniazid resistance, and nontuberculous mycobacteria in a low-incidence setting.
    J Clin Microbiol. 2024 Sep 19:e0040224. doi: 10.1128/jcm.00402.
    PubMed     Abstract available
    
    
    
13. CABIBBE AM, Moghaddasi K, Batignani V, Morgan GSK, et al
    Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies.
    J Clin Microbiol. 2024 Sep 6:e0081524. doi: 10.1128/jcm.00815.
    PubMed     Abstract available
    
    
    August 2024
14. BUENESTADO-SERRANO S, Martinez-Lirola M, Dippenaar A, Sanz-Perez A, et al
    Bridging the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data.
    J Clin Microbiol. 2024 Aug 13:e0074124. doi: 10.1128/jcm.00741.
    PubMed     Abstract available
    
    
    July 2024
15. OMAR SV, Louw G, Ismail F, Liu X, et al
    Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa.
    J Clin Microbiol. 2024 Jul 26:e0022924. doi: 10.1128/jcm.00229.
    PubMed     Abstract available
    
    
    
16. AKINAGA A, Takahashi M, Yamazaki T, Chikamatsu K, et al
    Development and preliminary evaluation toward a new tuberculosis treatment monitoring tool: the PATHFAST TB LAM Ag assay.
    J Clin Microbiol. 2024 Jul 19:e0062924. doi: 10.1128/jcm.00629.
    PubMed     Abstract available
    
    
    March 2024
17. WOOD RC, Luabeya AK, Dragovich RB, Olson AM, et al
    Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima.
    J Clin Microbiol. 2024 Mar 14:e0001924. doi: 10.1128/jcm.00019.
    PubMed     Abstract available
    
    
    
18. LUUKINEN B, Antikainen J, Aittoniemi J, Miikkulainen-Lahti T, et al
    Evaluation of the FluoroType Mycobacteria assay for identification of mycobacteria.
    J Clin Microbiol. 2024;62:e0105423.
    PubMed     Abstract available
    
    
    
19. DESRUISSEAUX C, Broderick C, Lavergne V, Sy K, et al
    Retrospective validation of MetaSystems' deep-learning-based digital microscopy platform with assistance compared to manual fluorescence microscopy for detection of mycobacteria.
    J Clin Microbiol. 2024;62:e0106923.
    PubMed     Abstract available
    
    
    
20. TRAM TTB, Trieu LPT, Nhat LTH, Thu DDA, et al
    Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis.
    J Clin Microbiol. 2024 Mar 11:e0128723. doi: 10.1128/jcm.01287.
    PubMed     Abstract available
    
    
    January 2024
21. DRAIN PK, Dalmat RR
    The elusive allure of a rapid host blood signature for tuberculosis disease.
    J Clin Microbiol. 2024 Jan 25:e0128923. doi: 10.1128/jcm.01289.
    PubMed     Abstract available
    
    
    December 2023
22. XIA Z, Su B, Tu C, Sun S, et al
    Single-tube protocol for culture-independent spoligotyping of Mycobacterium tuberculosis based on MeltArray.
    J Clin Microbiol. 2023 Dec 19:e0118323. doi: 10.1128/jcm.01183.
    PubMed     Abstract available
    
    
    
23. PENG L, Fang T, Cai Q, Li H, et al
    Rapid detection of Mycobacterium tuberculosis in sputum using CRISPR-Cas12b combined with cross-priming amplification in a single reaction.
    J Clin Microbiol. 2023 Dec 19:e0092323. doi: 10.1128/jcm.00923.
    PubMed     Abstract available
    
    
    October 2023
24. LI M, Qiu Y, Guo M, Qu R, et al
    Evaluation of the Cepheid 3-gene host response blood test for tuberculosis diagnosis and treatment response monitoring in a primary-level clinic in rural China.
    J Clin Microbiol. 2023 Oct 30:e0091123. doi: 10.1128/jcm.00911.
    PubMed     Abstract available
    
    
    
25. ISLAM MR, Sharma MK, KhunKhun R, Shandro C, et al
    Whole genome sequencing-based identification of human tuberculosis caused by animal-lineage Mycobacterium orygis.
    J Clin Microbiol. 2023 Oct 25:e0026023. doi: 10.1128/jcm.00260.
    PubMed     Abstract available
    
    
    
26. KOEPPEL L, Denkinger CM, Wyss R, Broger T, et al
    Diagnostic performance of host protein signatures as a triage test for active pulmonary TB.
    J Clin Microbiol. 2023;61:e0026423.
    PubMed     Abstract available
    
    
    
27. LU J, Murugesan K, Senchyna F, Budvytiene I, et al
    Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California.
    J Clin Microbiol. 2023 Oct 16:e0077523. doi: 10.1128/jcm.00775.
    PubMed     Abstract available
    
    
    September 2023
28. ZHANG X, Lam C, Martinez E, Sim E, et al
    Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants.
    J Clin Microbiol. 2023 Sep 26:e0048523. doi: 10.1128/jcm.00485.
    PubMed     Abstract available
    
    
    
29. MANN BC, Jacobson KR, Ghebrekristos Y, Warren RM, et al
    Assessment and validation of enrichment and target capture approaches to improve Mycobacterium tuberculosis WGS from direct patient samples.
    J Clin Microbiol. 2023 Sep 20:e0038223. doi: 10.1128/jcm.00382.
    PubMed     Abstract available
    
    
    June 2023
30. PILLAY S, de Vos M, Sohn H, Ghebrekristos Y, et al
    To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis.
    J Clin Microbiol. 2023 Jun 27:e0001723. doi: 10.1128/jcm.00017.
    PubMed     Abstract available
    
    
    
31. BURON V, Banaei N
    Inflated Gamma Interferon Response with QuantiFERON-TB Gold Plus Using the Automated Liaison XL Analyzer: a Testing Algorithm To Mitigate False-Positive Results in Low-Incidence Settings.
    J Clin Microbiol. 2023;61:e0029523.
    PubMed     Abstract available
    
    
    May 2023
32. CHEN X, Li R, Ge S, Li Y, et al
    Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
    J Clin Microbiol. 2023 May 30:e0183222. doi: 10.1128/jcm.01832.
    PubMed     Abstract available
    
    
    
33. ZHANG S, Chen X, Lin Z, Tan Y, et al
    Quantification of Isoniazid-Heteroresistant Mycobacterium tuberculosis Using Droplet Digital PCR.
    J Clin Microbiol. 2023 May 17:e0188422. doi: 10.1128/jcm.01884.
    PubMed     Abstract available
    
    
    April 2023
34. LOPEZ JM, Zimic M, Vallejos K, Sevilla D, et al
    Quantitative (1)H Nuclear Magnetic Resonance Assay for the Rapid Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis from Sputum Samples.
    J Clin Microbiol. 2023 Apr 18:e0152222. doi: 10.1128/jcm.01522.
    PubMed     Abstract available
    
    
    
35. TRAM TTB, Ha VTN, Trieu LPT, Ashton PM, et al
    FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum.
    J Clin Microbiol. 2023 Apr 3:e0163422. doi: 10.1128/jcm.01634.
    PubMed     Abstract available
    
    
    March 2023
36. SYED RR, Catanzaro DG, Colman RE, Cooney CG, et al
    Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    J Clin Microbiol. 2023;61:e0147822.
    PubMed     Abstract available
    
    
    
37. LU P, Wu K, Zhou H, Yu H, et al
    Evaluation of ESAT6-CFP10 Skin Test for Mycobacterium tuberculosis Infection among Persons Living with HIV in China.
    J Clin Microbiol. 2023 Mar 22:e0181622. doi: 10.1128/jcm.01816.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.